DOCSLIB.ORG

Pages 1–204 Anna Dumitriu (1969)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pages 1–204 Anna Dumitriu (1969) Pages 1–204 Pages Anna Dumitriu (1969). Make Do and Mend (detail), 2017. Ampicillin antibiotic susceptibility discs and fabric, 12 in x 12 in/30.48 cm x 30.48 cm. First exhibited at LifeSpace Dundee, 2017. Made in collaboration with Nicola Fawcett (University of Oxford) and Sarah Goldberg (Technion). Digital image courtesy of Anna Dumitriu. Peer-Reviewed Journal Tracking and Analyzing Disease Trends Pages 1–204 EDITOR-IN-CHIEF D. Peter Drotman Associate Editors EDITORIAL BOARD Paul Arguin, Atlanta, Georgia, USA Barry J. Beaty, Fort Collins, Colorado, USA Charles Ben Beard, Fort Collins, Colorado, USA Martin J. Blaser, New York, New York, USA Ermias Belay, Atlanta, Georgia, USA Richard Bradbury, Atlanta, Georgia, USA David Bell, Atlanta, Georgia, USA Christopher Braden, Atlanta, Georgia, USA Sharon Bloom, Atlanta, Georgia, USA Arturo Casadevall, New York, New York, USA Mary Brandt, Atlanta, Georgia, USA Kenneth C. Castro, Atlanta, Georgia, USA Corrie Brown, Athens, Georgia, USA Benjamin J. Cowling, Hong Kong, China Charles Calisher, Fort Collins, Colorado, USA Vincent Deubel, Shanghai, China Michel Drancourt, Marseille, France Christian Drosten, Charité Berlin, Germany Paul V. Effler, Perth, Australia Isaac Chun-Hai Fung, Statesboro, Georgia, USA Anthony Fiore, Atlanta, Georgia, USA Kathleen Gensheimer, College Park, Maryland, USA David Freedman, Birmingham, Alabama, USA Rachel Gorwitz, Atlanta, Georgia, USA Peter Gerner-Smidt, Atlanta, Georgia, USA Duane J. Gubler, Singapore Stephen Hadler, Atlanta, Georgia, USA Richard L. Guerrant, Charlottesville, Virginia, USA Matthew Kuehnert, Edison, New Jersey, USA Scott Halstead, Arlington, Virginia, USA Nina Marano, Atlanta, Georgia, USA David L. Heymann, London, UK Martin I. Meltzer, Atlanta, Georgia, USA Keith Klugman, Seattle, Washington, USA David Morens, Bethesda, Maryland, USA Takeshi Kurata, Tokyo, Japan J. Glenn Morris, Gainesville, Florida, USA S.K. Lam, Kuala Lumpur, Malaysia Patrice Nordmann, Fribourg, Switzerland Stuart Levy, Boston, Massachusetts, USA Ann Powers, Fort Collins, Colorado, USA John S. MacKenzie, Perth, Australia Didier Raoult, Marseille, France John E. McGowan, Jr., Atlanta, Georgia, USA Pierre Rollin, Atlanta, Georgia, USA Jennifer H. McQuiston, Atlanta, Georgia, USA Frank Sorvillo, Los Angeles, California, USA Tom Marrie, Halifax, Nova Scotia, Canada David Walker, Galveston, Texas, USA Nkuchia M. M’ikanatha, Harrisburg, Pennsylvania, USA J. Todd Weber, Atlanta, Georgia, USA Frederick A. Murphy, Bethesda, Maryland, USA Managing Editor Barbara E. Murray, Houston, Texas, USA Byron Breedlove, Atlanta, Georgia, USA Stephen M. Ostroff, Silver Spring, Maryland, USA Johann D. Pitout, Calgary, Alberta, Canada Copy Editors Kristina Clark, Dana Dolan, Karen Foster, Mario Raviglione, Geneva, Switzerland Thomas Gryczan, Michelle Moran, Shannon O’Connor, David Relman, Palo Alto, California, USA Jude Rutledge, P. Lynne Stockton, Deborah Wenger Guénaël Rodier, Saône-et-Loire, France Production Thomas Eheman, William Hale, Barbara Segal, Connie Schmaljohn, Frederick, Maryland, USA Reginald Tucker Tom Schwan, Hamilton, Montana, USA Editorial Assistants Kristine Phillips, Susan Richardson Rosemary Soave, New York, New York, USA P. Frederick Sparling, Chapel Hill, North Carolina, USA Communications/Social Media Sarah Logan Gregory, Robert Swanepoel, Pretoria, South Africa Tony Pearson-Clarke David E. Swayne, Athens, Georgia, USA Founding Editor Phillip Tarr, St. Louis, Missouri, USA Joseph E. McDade, Rome, Georgia, USA Duc Vugia, Richmond, California Emerging Infectious Diseases is published monthly by the Centers for Disease Control John Ward, Atlanta, Georgia, USA and Prevention, 1600 Clifton Rd NE, Mailstop H16-2, Atlanta, GA 30329-4027, USA. Jeffrey Scott Weese, Guelph, Ontario, Canada Telephone 404-639-1960, fax 404-639-1954, email [email protected]. Mary E. Wilson, Cambridge, Massachusetts, USA The conclusions, findings, and opinions expressed by authors contributing Use of trade names is for identification only and does not imply to this journal do not necessarily reflect the official position of the U.S. Depart- endorsement by the Public Health Service or by the U.S. Department of Health ment of Health and Human Services, the Public Health Service, the Centers for and Human Services. Disease Control and Prevention, or the authors’ affiliated institutions. Use of EMERGING INFECTIOUS DISEASES is a registered service mark of trade names is for identification only and does not imply endorsement by any the U.S. Department of Health & Human Services (HHS). of the groups named above. All material published in Emerging Infectious Diseases is in the public ∞ Emerging Infectious Diseases is printed on acid-free paper that meets the domain and may be used and reprinted without special permission; proper requirements of ANSI/NISO 239.48-1992 (Permanence of Paper) citation, however, is required. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No.1 , January 2019 January 2019 Effects of Antibiotic Cycling On the Cover Policy on Incidence of Healthcare-Associated MRSA and Anna Dumitriu Clostridioides difficileInfection (1969). Make Do and in Secondary Healthcare Settings Mend (detail), 2017. Ampicillin antibiotic G.M. Conlon-Bingham et al. 52 susceptibility discs Related material available online: and fabric, 12 in http://wwwnc.cdc.gov/eid/ x 12 in/30.48 cm article/25/1/18-0111_article x 30.48 cm. First exhibited at LifeSpace Association of Increased Dundee, 2017. Made Receptor-Binding Avidity of in collaboration Influenza A(H9N2) Viruses with Nicola Fawcett with Escape from Antibody- (University of Oxford) Based Immunity and and Sarah Goldberg Enhanced Zoonotic Potential (Technion). Digital J.E. Sealy et al. 63 image courtesy of Related material available online: Anna Dumitriu. http://wwwnc.cdc.gov/eid/ article/25/1/18-0616_article About the Cover p. 198 Variable Protease-Sensitive Prionopathy Transmission to Bank Voles Perspective R. Nonno et al. 73 Related material available online: Complexity of the Basic Enterovirus A71 Infection http://wwwnc.cdc.gov/eid/ Reproduction Number (R ) article/25/1/18-0807_article 0 and Neurologic Disease, P.L. Delamater et al. 1 Madrid, Spain, 2016 Zoonotic Source Attribution of For children with brainstem encephalitis Salmonella enterica Serotype or encephalomyelitis, clinicians should Typhimurium Using Genomic Synopses look for enterovirus and not limit testing Surveillance Data, United States Aeromedical Transfer of Patients to cerebrospinal fluid. with Viral Hemorrhagic Fever C.N. Taravilla et al. 25 S. Zhang et al. 82 E.D. Nicol et al. 5 Related material available online: http://wwwnc.cdc.gov/eid/ article/25/1/18-0835_article Clinical and Radiologic Research Characteristics of Human Metapneumovirus Infections in Epidemiology of Imported Multiple Introductions of Adults, South Korea Infectious Diseases, Domestic Cat Feline China, 2005–2016 Leukemia Virus in Endangered H.J. Koo et al. 15 Y. Wang et al. 33 Florida Panthers Related material available online: http://wwwnc.cdc.gov/eid/ E.S. Chiu et al. 92 article/25/1/18-1131_article Risk Factors for Elizabethkingia Related material available online: Acquisition and Clinical http://wwwnc.cdc.gov/eid/ Characteristics of Patients, article/25/1/18-1347_article South Korea M.H. Choi et al. 42 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 1, January 2019 Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, January 2019 Malawi, 2004–2010 Cotrimoxazole preventive therapy may lead to fewer prescriptions. A.C. Ewing et al. 102 Dispatches Dengue Virus IgM Serotyping by ELISA with Recombinant Mutant Envelope Proteins A. Rockstroh et al. 112 Related material available online: http://wwwnc.cdc.gov/eid/ article/25/1/18-0605_article Influenza H5/H7 Virus Vaccination in Poultry and Reduction of Zoonotic Infections, Guangdong Province, China, 2017–18 J. Wu et al. 116 The installation Make Do and Mend by Anna Dumitriu explores CRISPR gene editing and antibiotic resistance. It features an altered antique women’s suit with CC41 mark, antique toy Higher Viral Load of Emerging sewing machine, silk impregnated with CRISPR edited bacteria, altered vintage leaflets, ampicillin Norovirus GII.P16-GII.2 than antibiotic susceptibility discs, fabric, wood and glass frames. First exhibited at LifeSpace Dundee, Pandemic GII.4 and Epidemic 2017. Made in collaboration with Sarah Goldberg and Roee Amit (Technion) with elements in collaboration with Nicola Fawcett (University of Oxford). Digital image courtesy of Anna Dumitriu. GII.17, Hong Kong, China S.K.C. Cheung et al. 119 Identification ofLonepinella sp. Related material available online: Puumala Hantavirus http://wwwnc.cdc.gov/eid/ in Koala Bite Wound Infections, Genotypes in Humans, article/25/1/18-0395_article Queensland, Australia France, 2012–2016 H.A. Sinclair et al. 153 J.-M. Reynes et al. 140 Autochthonous Transmission Related material available online: of Coccidioides in Animals, Related material available online: http://wwwnc.cdc.gov/eid/ Washington, USA http://wwwnc.cdc.gov/eid/ article/25/1/17-1359_article article/25/1/18-0270_article A.E. James et al. 123 Surgical Site Infections New Multidrug-Resistant Caused by Highly Virulent Meat and Fish as Sources Salmonella enterica Serovar Methicillin-Resistant of Extended-Spectrum Anatum Clone, Taiwan, Staphylococcus aureus β-Lactamase–Producing 2015–2017 Escherichia coli, Cambodia Sequence Type 398, China C.-S. Chiou et al. 144 L. Sun et al. 157 M. Nadimpalli et al. 126 Related
Load more

Recommended publications
  • Persistence of Ebola Virus in Various Body Fluids During Convalescence
    Epidemiol. Infect. (2016), 144, 1652–1660. © Cambridge University Press 2016 doi:10.1017/S0950268816000054 Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control A. A. CHUGHTAI*, M. BARNES AND C. R. MACINTYRE School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia Received 19 November 2015; Final revision 22 December 2015; Accepted 6 January 2016; first published online 25 January 2016 SUMMARY The aim of this study was to review the current evidence regarding the persistence of Ebola virus (EBOV) in various body fluids during convalescence and discuss its implication on disease transmission and control. We conducted a systematic review and searched articles from Medline and EMBASE using key words. We included studies that examined the persistence of EBOV in various body fluids during the convalescent phase. Twelve studies examined the persistence of EBOV in body fluids, with around 800 specimens tested in total. Available evidence suggests that EBOV can persist in some body fluids after clinical recovery and clearance of virus from the blood. EBOV has been isolated from semen, aqueous humor, urine and breast milk 82, 63, 26 and 15 days after onset of illness, respectively. Viral RNA has been detectable in semen (day 272), aqueous humor (day 63), sweat (day 40), urine (day 30), vaginal secretions (day 33), conjunctival fluid (day 22), faeces (day 19) and breast milk (day 17). Given high case fatality and uncertainties around the transmission characteristics, patients should be considered potentially infectious for a period of time after immediate clinical recovery.
    [Show full text]
  • Global Burden of Norovirus and Prospects for Vaccine Development
    Global Burden of Norovirus and Prospects for Vaccine Development Primary author Ben Lopman Centers for Disease Control and Prevention Contributors and Reviewers Robert Atmar, Baylor College of Medicine Ralph Baric, University of North Carolina Mary Estes, Baylor College of Medicine Kim Green, NIH; National Institute of Allergy and Infectious Diseases Roger Glass, NIH; Fogarty International Center Aron Hall, Centers for Disease Control and Prevention Miren Iturriza-Gómara, University of Liverpool Cherry Kang, Christian Medical College Bruce Lee, Johns Hopkins University Umesh Parashar, Centers for Disease Control and Prevention Mark Riddle, Naval Medical Research Center Jan Vinjé, Centers for Disease Control and Prevention The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, or the US Department of Health and Human Services. This work was funded in part by a grant from the Bill & Melinda Gates Foundation to the CDC Foundation. GLOBAL BURDEN OF NOROVIRUS AND PROSPECTS FOR VACCINE DEVELOPMENT | 1 Table of Contents 1. Executive summary ....................................................................3 2. Burden of disease and epidemiology 7 a. Burden 7 i. Global burden and trends of diarrheal disease in children and adults 7 ii. The role of norovirus 8 b. Epidemiology 9 i. Early childhood infections 9 ii. Risk factors, modes and settings of transmission 10 iii. Chronic health consequences associated with norovirus infection? 11 c. Challenges in attributing disease to norovirus 12 3. Norovirus biology, diagnostics and their interpretation for field studies and clinical trials..15 a. Norovirus virology 15 i. Genetic diversity, evolution and related challenges for diagnosis 15 ii.
    [Show full text]
  • African Meningitis Belt
    WHO/EMC/BAC/98.3 Control of epidemic meningococcal disease. WHO practical guidelines. 2nd edition World Health Organization Emerging and other Communicable Diseases, Surveillance and Control This document has been downloaded from the WHO/EMC Web site. The original cover pages and lists of participants are not included. See http://www.who.int/emc for more information. © World Health Organization This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors. The mention of specific companies or specific manufacturers' products does no imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. CONTENTS CONTENTS ................................................................................... i PREFACE ..................................................................................... vii INTRODUCTION ......................................................................... 1 1. MAGNITUDE OF THE PROBLEM ........................................................3 1.1 REVIEW OF EPIDEMICS SINCE THE 1970S .......................................................................................... 3 Geographical distribution
    [Show full text]
  • Comparison of New Implantation of Cardiac Implantable Electronic
    www.nature.com/scientificreports OPEN Comparison of new implantation of cardiac implantable electronic device between tertiary and non‑tertiary hospitals: a Korean nationwide study Seungbong Han1, Gyung‑Min Park2, Yong‑Giun Kim2*, Ki Won Hwang3, Chang Hee Kwon4, Jae‑Hyung Roh5, Sangwoo Park2, Ki‑Bum Won2, Soe Hee Ann2, Shin‑Jae Kim2 & Sang‑Gon Lee2 This study compared the characteristics and mortality of new implantation of cardiac implantable electronic device (CIED) between tertiary and non‑tertiary hospitals. From national health insurance claims data in Korea, 17,655 patients, who underwent frst and new implantation of CIED between 2013 and 2017, were enrolled. Patients were categorized into the tertiary hospital group (n = 11,560) and non‑tertiary hospital group (n = 6095). Clinical outcomes including in‑hospital death and all‑cause death were compared between the two groups using propensity‑score matched analysis. Patients in non‑tertiary hospitals were older and had more comorbidities than those in tertiary hospitals. The study population had a mean follow‑up of 2.1 ± 1.2 years. In the propensity‑score matched permanent pacemaker group (n = 5076 pairs), the incidence of in‑hospital death (odds ratio [OR]: 0.76, 95% confdence interval [CI]: 0.43–1.32, p = 0.33) and all‑cause death (hazard ratio [HR]: 0.92, 95% CI 0.81–1.05, p = 0.24) were not signifcantly diferent between tertiary and non‑tertiary hospitals. These fndings were consistently observed in the propensity‑score matched implantable cardioverter‑ defbrillator group (n = 992 pairs, OR for in‑hospital death: 1.76, 95% CI 0.51–6.02, p = 0.37; HR for all‑cause death: 0.95, 95% CI 0.72–1.24, p = 0.70).
    [Show full text]
  • Aeromedical Transfer of Patients with Viral Hemorrhagic Fever Edward D
    SYNOPSIS Aeromedical Transfer of Patients with Viral Hemorrhagic Fever Edward D. Nicol, Stephen Mepham, Jonathan Naylor, Ian Mollan, Matthew Adam, Joanna d’Arcy, Philip Gillen, Emma Vincent, Belinda Mollan, David Mulvaney, Andrew Green, Michael Jacobs For >40 years, the British Royal Air Force has maintained high-risk and 2 intermediate-risk exposures, have been an aeromedical evacuation facility, the Deployable Air Iso- transferred (4,8–10) (Table 1). lator Team (DAIT), to transport patients with possible or In the United Kingdom, 2 high-level isolation units confirmed highly infectious diseases to the United King- (HLIU) are primarily responsible for the care of patients dom. Since 2012, the DAIT, a joint Department of Health with viral hemorrhagic fevers (VHFs): the Royal Free and Ministry of Defence asset, has successfully trans- Hospital, London, and the Royal Victoria Infirmary, New- ferred 1 case-patient with Crimean-Congo hemorrhagic fever, 5 case-patients with Ebola virus disease, and 5 castle. Both units use the Trexler patient isolator, in which case-patients with high-risk Ebola virus exposure. Cur- patient care is provided within an isolation tent. End-to-end rently, no UK-published guidelines exist on how to transfer maximal patient containment from overseas to the receiv- such patients. Here we describe the DAIT procedures from ing hospital and subsequent discharge is achieved through collection at point of illness or exposure to delivery into a the T-ATI (Figure 1), which is designed to interface with dedicated specialist center. We provide illustrations of the the Trexler isolator. The T-ATI is transported on a suitable challenges faced and, where appropriate, the enhance- aircraft and from the airhead using a dedicated ambulance, ments made to the process over time.
    [Show full text]
  • Article (Published Version)
    Article The 2014–2015 Ebola outbreak in West Africa: Hands On VETTER, Pauline, et al. Reference VETTER, Pauline, et al. The 2014–2015 Ebola outbreak in West Africa: Hands On. Antimicrobial Resistance and Infection Control, 2016, vol. 5, no. 1 DOI : 10.1186/s13756-016-0112-9 Available at: http://archive-ouverte.unige.ch/unige:106949 Disclaimer: layout of this document may differ from the published version. 1 / 1 Vetter et al. Antimicrobial Resistance and Infection Control (2016) 5:17 DOI 10.1186/s13756-016-0112-9 MEETING REPORT Open Access The 2014–2015 Ebola outbreak in West Africa: Hands On Pauline Vetter1,2, Julie-Anne Dayer2, Manuel Schibler2, Benedetta Allegranzi3, Donal Brown4, Alexandra Calmy5, Derek Christie6,7, Sergey Eremin3, Olivier Hagon8, David Henderson9, Anne Iten1, Edward Kelley3, Frederick Marais10, Babacar Ndoye11, Jérôme Pugin12, Hugues Robert-Nicoud13, Esther Sterk13, Michael Tapper14, Claire-Anne Siegrist15, Laurent Kaiser2 and Didier Pittet1* Abstract The International Consortium for Prevention and Infection Control (ICPIC) organises a biannual conference (ICPIC) on various subjects related to infection prevention, treatment and control. During ICPIC 2015, held in Geneva in June 2015, a full one-day session focused on the 2014–2015 Ebola virus disease (EVD) outbreak in West Africa. This article is a non-exhaustive compilation of these discussions. It concentrates on lessons learned and imagining a way forward for the communities most affected by the epidemic. The reader can access video recordings of all lectures delivered during this one-day session, as referenced. Topics include the timeline of the international response, linkages between the dynamics of the epidemic and infection prevention and control, the importance of community engagement, and updates on virology, diagnosis, treatment and vaccination issues.
    [Show full text]
  • Novel Risk Factors for Coronavirus Disease-Associated Mucormycosis (CAM): a Case Control Study During the Outbreak in India
    medRxiv preprint doi: https://doi.org/10.1101/2021.07.24.21261040; this version posted July 26, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Novel risk factors for Coronavirus disease-associated mucormycosis (CAM): a case control study during the outbreak in India Umang Arora1, Megha Priyadarshi1, Varidh Katiyar2, Manish Soneja1, Prerna Garg1, Ishan Gupta1,- Vishwesh Bharadiya1, Parul Berry1, Tamoghna Ghosh1, Lajjaben Patel1 , Radhika Sarda1, Shreya Garg3, Shubham Agarwal1, Veronica Arora4, Aishwarya Ramprasad1, Amit Kumar1, Rohit Kumar Garg1, Parul Kodan1, Neeraj Nischal1, Gagandeep Singh5, Pankaj Jorwal1, Arvind Kumar1, Upendra Baitha1, Ved Prakash Meena1, Animesh Ray1, Prayas Sethi1, , Immaculata Xess5, Naval Vikram1, Sanjeev Sinha1, Ashutosh Biswas1,Alok Thakar3, Sushma Bhatnagar6, Anjan Trikha7, Naveet Wig1 1Department of Medicine, AIIMS, Delhi, India 2Department of Neurosurgery, AIIMS, Delhi, India 3Department of Otolaryngology & Head-Neck Surgery, AIIMS, Delhi, India 4Department of Medical Genetics, Sir Ganga Ram Hospital, Delhi, India 5Department of Microbiology, AIIMS, Delhi, India 6Department of Onco-anaesthesia and Palliative Medicine, AIIMS, Delhi, India 7Department of Anaesthesiology, Pain Medicine and Critical Care, AIIMS, Delhi, India 1. Umang Arora, MD (Medicine), Junior Resident, Department of Medicine, AIIMS, Delhi, India. E-mail ID: [email protected] 2. Megha Priyadarshi, DM (Infectious disease), Junior Resident, Department of Medicine, AIIMS, Delhi, India. E-mail ID: [email protected] 3. Varidh Katiyar, MCh (Neurosurgery), Chief Resident, Department of Neurosurgery AIIMS, Delhi, India. E-mail ID: [email protected] 4.
    [Show full text]
  • Extended Deterrence and Strategic Stability in East Asia: AY19 Strategic Deterrence Research Papers (Vol I)
    ExtendedFuture Warfare Deterrence Series No. and 10203040 DefendingAvoidingStrategicTheThe “WorriedAnthrax thePanic Stability American Vaccine Well”and in Keeping ResponseEast Debate: Homeland Asia: the A MedicalPortsAY19 Opento StrategicReview CBRN1993-2003 in a Events:forChemical Deterrence Commanders and BiologicalResearchAnalysis Threat andPapers Solu�onsEnvironment (Vol I) A Literature Review TanjaLieutenantRandallMajor M. Korpi J.Richard ColonelLarsen andEdited A.Christopherand Fred Hersack,by: Patrick P. Stone, USAF D.Hemmer EllisUSAF Dr. Paige P. Cone Dr. James Platte Dr. R. Lewis Steinhoff United States Air Force Center for Strategic Deterrence Studies 30204010 Maxwell Air Force Base, Alabama Extended Deterrence and Strategic Stability in East Asia: AY19 Strategic Deterrence Research Papers (Vol I) Edited by Dr. Paige P. Cone Dr. James E. Platte Dr. R. Lewis Steinhoff USAF Center for Strategic Deterrence Studies 125 Chennault Circle Maxwell Air Force Base, Alabama 36112 August 2019 Table of Contents Chapter Page Disclaimer ..………………………………………………..….……….….……...ii Preface ..…………………………………………………….………..….….…... iii Chapter 1. Introduction ……………………………………………….….………1 Chapter 2. Assuring the Republic of Korea through Nuclear Sharing: A Blueprint for an Asian Ally Col. Jordan E. Murphy, U.S. Air Force………………………..…………….……5 Chapter 3. Missile Defense in South Korea Lt. Col. Elizabeth T. Benedict, U.S. Air Force…………………...……………….…23 Chapter 4. United States Air Force Posture: Impacts to Japanese Assurance in the Indo-PACOM AOR Maj. Jonathan P.
    [Show full text]
  • Review Article Ebola Virus Infection Among Western Healthcare Workers Unable to Recall the Transmission Route
    Hindawi Publishing Corporation BioMed Research International Volume 2016, Article ID 8054709, 5 pages http://dx.doi.org/10.1155/2016/8054709 Review Article Ebola Virus Infection among Western Healthcare Workers Unable to Recall the Transmission Route Stefano Petti,1 Carmela Protano,1 Giuseppe Alessio Messano,1 and Crispian Scully2 1 Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy 2University College London, London, UK Correspondence should be addressed to Stefano Petti; [email protected] Received 23 October 2016; Accepted 13 November 2016 Academic Editor: Charles Spencer Copyright © 2016 Stefano Petti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. During the 2014–2016 West-African Ebola virus disease (EVD) outbreak, some HCWs from Western countries became infected despite proper equipment and training on EVD infection prevention and control (IPC) standards. Despite their high awareness toward EVD, some of them could not recall the transmission routes. Weexplored these incidents by recalling the stories of infected Western HCWs who had no known directly exposures to blood/bodily fluids from EVD patients. Methodology. We carried out conventional and unconventional literature searches through the web using the keyword “Ebola” looking for interviews and reports released by the infected HCWs and/or the healthcare organizations. Results. We identified fourteen HCWs, some infected outside West Africa and some even classified at low EVD risk. None of them recalled accidents, unintentional exposures, or anyIPC violation. Infection transmission was thus inexplicable through the acknowledged transmission routes.
    [Show full text]
  • Vaccines and Global Health :: Ethics and Policy
    Vaccines and Global Health: The Week in Review 10 October 2015 Center for Vaccine Ethics & Policy (CVEP) This weekly summary targets news, events, announcements, articles and research in the vaccine and global health ethics and policy space and is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. Vaccines and Global Health: The Week in Review is also posted in pdf form and as a set of blog posts at http://centerforvaccineethicsandpolicy.wordpress.com/. This blog allows full-text searching of over 8,000 entries. Comments and suggestions should be directed to David R. Curry, MS Editor and Executive Director Center for Vaccine Ethics & Policy [email protected] Request an email version: Vaccines and Global Health: The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to [email protected]. Contents [click on link below to move to associated content] A. Ebola/EVD; Polio; MERS-Cov B. WHO; CDC C. Announcements/Milestones D. Reports/Research/Analysis E. Journal Watch F. Media Watch :::::: :::::: EBOLA/EVD [to 10 October 2015] Public Health Emergency of International Concern (PHEIC); "Threat to international peace and security" (UN Security Council) Ebola Situation Report - 30 September 2015 [Excerpts] SUMMARY [excerpt] No confirmed cases of Ebola virus disease (EVD) were reported in the week to 4 October.
    [Show full text]
  • The Interaction Between Human Antimicrobial Use and the Risk of Foodborne Zoonotic Bacteria
    Downloaded from orbit.dtu.dk on: Dec 20, 2017 The interaction between human antimicrobial use and the risk of foodborne zoonotic bacteria Koningstein, Maike; Hald, Tine; Mølbak, Kåre Publication date: 2014 Document Version Peer reviewed version Link back to DTU Orbit Citation (APA): Koningstein, M., Hald, T., & Mølbak, K. (2014). The interaction between human antimicrobial use and the risk of foodborne zoonotic bacteria. National Food Institute, Technical University of Denmark. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. The interaction between human antimicrobial use and the risk of foodborne zoonotic bacteria Maike Koningstein, M.Sc. PhD Thesis 2013 Statens Serum Institute Department of Infectious Disease Epidemiology Artillerivej 5, 2300 Copenhagen, Denmark and National Food Institute, DTU Department for Microbiology
    [Show full text]
  • ECDC/EFSA Joint Report: Avian Influenza Overview October
    SCIENTIFIC REPORT APPROVED: 29 September 2017 doi: 10.2903/j.efsa.2017.5018 Avian influenza overview October 2016–August 2017 European Food Safety Authority, European Centre for Disease Prevention and Control, European Union Reference Laboratory for Avian influenza, Ian Brown, Paolo Mulatti, Krzysztof Smietanka, Christoph Staubach, Preben Willeberg, Cornelia Adlhoch, Denise Candiani, Chiara Fabris, Gabriele Zancanaro, Joana Morgado and Frank Verdonck Abstract The A(H5N8) highly pathogenic avian influenza (HPAI) epidemic occurred in 29 European countries in 2016/2017 and has been the largest ever recorded in the EU in terms of number of poultry outbreaks, geographical extent and number of dead wild birds. Multiple primary incursions temporally related with all major poultry sectors affected but secondary spread was most commonly associated with domestic waterfowl species. A massive effort of all the affected EU Member States (MSs) allowed a descriptive epidemiological overview of the cases in poultry, captive birds and wild birds, providing also information on measures applied at the individual MS level. Data on poultry population structure are required to facilitate data and risk factor analysis, hence to strengthen science-based advice to risk managers. It is suggested to promote common understanding and application of definitions related to control activities and their reporting across MSs. Despite a large number of human exposures to infected poultry occurred during the ongoing outbreaks, no transmission to humans has been identified. Monitoring the avian influenza (AI) situation in other continents indicated a potential risk of long-distance spread of HPAI virus (HPAIV) A(H5N6) from Asia to wintering grounds towards Western Europe, similarly to what happened with HPAIV A(H5N8) and HPAIV A(H5N1) in previous years.
    [Show full text]